Vanguard Group Inc Reviva Pharmaceuticals Holdings, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,804,092 shares of RVPH stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,804,092
Previous 1,384,592
30.3%
Holding current value
$1.3 Million
Previous $2.4 Million
28.48%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RVPH
# of Institutions
56Shares Held
7.42MCall Options Held
938KPut Options Held
62.1K-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$1.1 Million0.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$468,5200.16% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$367,4360.03% of portfolio
-
Geode Capital Management, LLC Boston, MA419KShares$301,7800.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY258KShares$185,9010.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $14.7M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...